APA

Fraser H., Hislop C., Christie R. M., Rick H. L., Reidy C. A., Chouinard M. L., Eacho P. I., Gould K. E. & Trias J. (20100920). Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice. : Journal of cardiovascular pharmacology.

Chicago

Fraser Heather, Hislop Colin, Christie Robert M, Rick Heather L, Reidy Charles A, Chouinard Michael L, Eacho Patrick I, Gould Kenneth E and Trias Joaquim. 20100920. Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice. : Journal of cardiovascular pharmacology.

Harvard

Fraser H., Hislop C., Christie R. M., Rick H. L., Reidy C. A., Chouinard M. L., Eacho P. I., Gould K. E. and Trias J. (20100920). Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice. : Journal of cardiovascular pharmacology.

MLA

Fraser Heather, Hislop Colin, Christie Robert M, Rick Heather L, Reidy Charles A, Chouinard Michael L, Eacho Patrick I, Gould Kenneth E and Trias Joaquim. Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice. : Journal of cardiovascular pharmacology. 20100920.